Jun 9, 2020Paper

A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures

BioRxiv : the Preprint Server for Biology
Kenneth H DinnonRalph S Baric


Coronaviruses are prone to emergence into new host species most recently evidenced by SARS-CoV-2, the causative agent of the COVID-19 pandemic. Small animal models that recapitulate SARS-CoV-2 disease are desperately needed to rapidly evaluate medical countermeasures (MCMs). SARS-CoV-2 cannot infect wildtype laboratory mice due to inefficient interactions between the viral spike (S) protein and the murine ortholog of the human receptor, ACE2. We used reverse genetics to remodel the S and mACE2 binding interface resulting in a recombinant virus (SARS-CoV-2 MA) that could utilize mACE2 for entry. SARS-CoV-2 MA replicated in both the upper and lower airways of both young adult and aged BALB/c mice. Importantly, disease was more severe in aged mice, and showed more clinically relevant phenotypes than those seen in hACE2 transgenic mice. We then demonstrated the utility of this model through vaccine challenge studies in immune competent mice with native expression of mACE2. Lastly, we show that clinical candidate interferon (IFN) lambda-1a can potently inhibit SARS-CoV-2 replication in primary human airway epithelial cells in vitro , and both prophylactic and therapeutic administration diminished replication in mice. Our mouse-adapt...Continue Reading


Jul 24, 2020·Viruses·Nikolaus OsterriederJakob Trimpert
Aug 28, 2020·Expert Review of Vaccines·Naru ZhangLanying Du
Jun 20, 2020·GeroScience·Brandt D Pence
Sep 29, 2020·Frontiers in Immunology·Inmaculada Sanclemente-AlamanUlises Gómez-Pinedo
Jul 14, 2020·Frontiers in Immunology·Marisa MarketRebecca C Auer
Jun 4, 2020·Pathogens·Sabari Nath Neerukonda, Upendra Katneni
Aug 21, 2020·Mucosal Immunology·M D JohansenP M Hansbro
Oct 1, 2020·Scientific Reports·Yuan ZhaoXiaozhong Peng
Aug 28, 2020·Frontiers in Microbiology·Lirong BaoJianxun Sun
Oct 8, 2020·Critical Care : the Official Journal of the Critical Care Forum·Salleh N EhaidebAbderrezak Bouchama
Oct 20, 2020·Emerging Microbes & Infections·Raveen RathnasingheMelissa B Uccellini
Oct 25, 2020·Proceedings of the National Academy of Sciences of the United States of America·Lisa MiorinAdolfo García-Sastre
Dec 1, 2020·Emerging Microbes & Infections·Kyle RosenkeHeinz Feldmann
Nov 4, 2020·Proceedings of the National Academy of Sciences of the United States of America·Wei LiDimiter S Dimitrov
Feb 16, 2021·Frontiers in Immunology·Bing XieYou Shang
Oct 30, 2020·Nature Reviews. Microbiology·Philip V'kovskiVolker Thiel
May 11, 2021·Frontiers in Pharmacology·G KanimozhiN Rajendra Prasad

❮ Previous
Next ❯

Related Concepts

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.

Related Papers

BioRxiv : the Preprint Server for Biology
Kenneth H DinnonRalph S. Baric
European Review for Medical and Pharmacological Sciences
Y-X BaiK-W Ma
BioRxiv : the Preprint Server for Biology
R. AhmedMd Shahidul Islam
© 2021 Meta ULC. All rights reserved